Insider Trading & Ownership of Royalty Pharma plc

Location
New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Vlad Coric
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Royalty Pharma plc and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Royalty Pharma plc has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value is not available.
  • No recent insider transactions are currently listed.

What Changed

  • Largest disclosed position: Royalty Pharma plc ($0).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Royalty Pharma plc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RPRX Royalty Pharma plc Director $0 07 Apr 2025

There are no insider transactions reported by Royalty Pharma plc